Literature DB >> 8457977

Compounds active against cell walls of medically important fungi.

R F Hector1.   

Abstract

A number of substances that directly or indirectly affect the cell walls of fungi have been identified. Those that actively interfere with the synthesis or degradation of polysaccharide components share the property of being produced by soil microbes as secondary metabolites. Compounds specifically interfering with chitin or beta-glucan synthesis have proven effective in studies of preclinical models of mycoses, though they appear to have a restricted spectrum of coverage. Semisynthetic derivatives of some of the natural products have offered improvements in activity, toxicology, or pharmacokinetic behavior. Compounds which act on the cell wall indirectly or by a secondary mechanism of action, such as the azoles, act against diverse fungi but are usually fungistatic in nature. Overall, these compounds are attractive candidates for further development.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8457977      PMCID: PMC358263          DOI: 10.1128/CMR.6.1.1

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  216 in total

1.  Isolation of Streptomyces tendae mutants with an altered nikkomycin spectrum.

Authors:  C Bormann; S Mattern; H Schrempf; H P Fiedler; H Zähner
Journal:  J Antibiot (Tokyo)       Date:  1989-06       Impact factor: 2.649

2.  Chitin and yeast budding. Localization of chitin in yeast bud scars.

Authors:  E Cabib; B Bowers
Journal:  J Biol Chem       Date:  1971-01-10       Impact factor: 5.157

Review 3.  Melanins and their importance in pathogenic fungi.

Authors:  M H Wheeler; A A Bell
Journal:  Curr Top Med Mycol       Date:  1988

4.  Cell wall composition and protoplast regeneration in Candida albicans.

Authors:  M V Elorza; H Rico; D Gozalbo; R Sentandreu
Journal:  Antonie Van Leeuwenhoek       Date:  1983-11       Impact factor: 2.271

5.  Isolation of a chitin synthase gene (CHS1) from Candida albicans by expression in Saccharomyces cerevisiae.

Authors:  J Au-Young; P W Robbins
Journal:  Mol Microbiol       Date:  1990-02       Impact factor: 3.501

6.  The structure of a beta-(1 leads to 3)-D-glucan from yeast cell walls.

Authors:  D J Manners; A J Masson; J C Patterson
Journal:  Biochem J       Date:  1973-09       Impact factor: 3.857

7.  Synthesis and anticandidal properties of polyoxin L analogues containing alpha-amino fatty acids.

Authors:  R K Khare; J M Becker; F R Naider
Journal:  J Med Chem       Date:  1988-03       Impact factor: 7.446

8.  Metabolic products of microorganisms. 252. Isolation of new nikkomycins from Streptomyces tendae.

Authors:  H Decker; C Bormann; H P Fiedler; H Zähner; H Heitsch; W A König
Journal:  J Antibiot (Tokyo)       Date:  1989-02       Impact factor: 2.649

9.  The function of chitin synthases 2 and 3 in the Saccharomyces cerevisiae cell cycle.

Authors:  J A Shaw; P C Mol; B Bowers; S J Silverman; M H Valdivieso; A Durán; E Cabib
Journal:  J Cell Biol       Date:  1991-07       Impact factor: 10.539

10.  The interaction of polyene antibiotics with thin lipid membranes.

Authors:  T E Andreoli; M Monahan
Journal:  J Gen Physiol       Date:  1968-08       Impact factor: 4.086

View more
  66 in total

Review 1.  Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance.

Authors:  M A Ghannoum; L B Rice
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

Review 2.  Mechanisms of fungal resistance: an overview.

Authors:  Maher M Balkis; Steven D Leidich; Pranab K Mukherjee; Mahmoud A Ghannoum
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Sensitive assay for antifungal activity of glucan synthase inhibitors that uses germ tube formation in Candida albicans as an end point.

Authors:  Timothy G Brayman; John W Wilks
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

Review 4.  Antifungal agents: in vitro susceptibility testing, pharmacodynamics, and prospects for combination therapy.

Authors:  A H Groll; H Kolve
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-11       Impact factor: 3.267

5.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

6.  Total Synthesis of (+)-Papulacandin D.

Authors:  Scott E Denmark; Tetsuya Kobayashi; Christopher S Regens
Journal:  Tetrahedron       Date:  2010-06-26       Impact factor: 2.457

7.  A mobile tryptophan is the intrinsic charge transfer donor in a flavoenzyme essential for nikkomycin antibiotic biosynthesis.

Authors:  Robert C Bruckner; Gouhua Zhao; Patricia Ferreira; Marilyn Schuman Jorns
Journal:  Biochemistry       Date:  2007-01-23       Impact factor: 3.162

8.  Thioridazine inhibits gene expression control of the cell wall signaling pathway (CWI) in the human pathogenic fungus Paracoccidioides brasiliensis.

Authors:  Daniela Leite Jabes; Ana Claudia de Freitas Oliveira; Valquíria Campos Alencar; Fabiano Bezerra Menegidio; Débora Liliane Souza Reno; Daiene Souza Santos; David Aciole Barbosa; Renata Ozelami Vilas Boas; Rodrigo Luiz de Oliveira Rodrigues Cunha; Tiago Rodrigues; Regina Costa de Oliveira; Luiz R Nunes
Journal:  Mol Genet Genomics       Date:  2016-03-08       Impact factor: 3.291

9.  Potential use of BacT/Alert automated blood culture system for antifungal susceptibility testing.

Authors:  K C Hazen; M P Chery; Y Han
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

10.  Antifungal activity of Ferulago capillaris essential oil against Candida, Cryptococcus, Aspergillus and dermatophyte species.

Authors:  E Pinto; K Hrimpeng; G Lopes; S Vaz; M J Gonçalves; C Cavaleiro; L Salgueiro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-26       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.